Abstract: Three hundred cases of cysticercosis cellulosae (175 cerebral, 125 subcutaneous-muscular) were treated orally with albendazole, 15-20 mg/kg/day for a 10-day course. Every patient received 3 treatment courses with an interval of two or three weeks.After 6-12 months, the therapeutic effect of albendazole was estimated in subcutaneous-muscular cases by the number of subcutaneous nodules, the activity and the morphological change of larvae in cerebral cases by the neuropsychic symptoms, CSF changes, CT findings and the degrees of recovery in physical and mental ability.The result showed that in the cases of subcutaneous-muscular cysticercosis the cure rate was 64.0%;the rate of significant effect, 25.6%; and that of clinical improvement, 10.4%; while in the cases of cerebral cysticercosis the rates were 40.6, 44.0 and 15.4%, respectively.